-0.25 (-0.02%) Dr. Reddy’s Laboratories enclosed a Press Release on ‘Dr. Reddy's Laboratories announces the launch of the generic version of Nexavar (sorafenib) Tablets, USP, 200 mg in the U.S. market’.
The above information is a part of company’s filings submitted to BSE.